Imunon is focusing TheraPlas on developing treatments for aggressive, hard-to-treat cancers, starting with ovarian. Its lead ...

Christiane Amanpour has been diagnosed with cancer again. The 67-year-old chief international anchor for CNN shared the news ...

Ovarcome is an ovarian cancer foundation envisioned to end the scourge of ovarian cancer. The Ovarcoming Cancer Conference brings together survivors, caregivers, and medical professionals to learn ...

Adelaide researchers have identified a promising new biomarker and treatment target for ovarian cancer that could markedly ...

The FDA has granted fast track designation to JSKN003, a biparatopic HER2-targeting antibody-drug conjugate (ADC), for the ...

Please provide your email address to receive an email when new articles are posted on . CHICAGO — In this video, Susana M. Campos, MD, MPH, discusses results from the ROSELLA phase 3 study of ...

Behind every pink ribbon this October, millions are struggling with pain and disability from a disease that rarely makes headlines.

GLP-1 receptor agonists are linked to a 55% reduction in mortality risk in women with ovarian cancer, based on a retrospective cohort study. The study utilized data from the TriNetX Research Network, ...

Women with epithelial ovarian cancer who happened to be taking nonselective beta-blockers for hypertension survived longer than those who were not taking the drugs, according to a large multicenter ...

A Sunshine Coast woman has shared how a routine health check accidentally uncovered ovarian cancer, and how medication restrictions sparked a full flush of menopause symptoms.

A simple procedure during routine surgery could prevent thousands of Australian women from getting ovarian cancer.

Women with ovarian cancer are being failed by a deadly postcode lottery in diagnosis and treatment that can mean the difference between life and death, a damning new report has revealed. The study, ...